Judith G. Levin,
Ph.D., Principal Investigator
Jianhui Guo, M.D., Ph.D., Staff
Scientist
Shixing Tang, M.D., Ph.D., Staff
Scientist
Yasumasa Iwatani, Ph.D., Postdoctoral
Fellow
Klara Post, M.S., Senior
Research Assistant
Brenda Soto, B.S., Predoctoral
Fellow
For More Information
|
|
|
The goal of the research performed in the Section on Viral Gene Regulation
is to define the molecular mechanisms involved in the replication of HIV
and related retroviruses. The research is critical for developing new
strategies to combat the AIDS epidemic, which has spread to all parts
of the world and poses a serious threat to human health and security.
We have developed reconstituted model systems to investigate HIV-1 reverse
transcription and the role of the viral nucleocapsid protein (NC), which
promotes highly efficient and specific viral DNA synthesis. Other studies,
performed in cell culture, are directed toward elucidating the function
of the viral capsid protein (CA) in virus assembly and early postentry
events.
Role of Nucleocapsid Protein in HIV-1 Strand Transfer
Guo, Wu,* Levin in collaboration with Henderson,a
Gorelick,a Musier-Forsythb
During reverse transcription, two strand transfer events are required
for synthesis of full-length plus- and minus-strand DNA copies of the
viral RNA genome. The process is efficient only when NC is present. HIV-1
NC has two zinc fingers, each containing invariant CCHC zinc-coordinating
residues and other residues that form three short loops; only the sequence
of the second loop is identical in both zinc fingers. A major question
concerns the functional significance of the two zinc fingers in HIV-1
NC. Recently, we reported the first direct evidence that zinc coordination
is required for the nucleic acid chaperone activity of NC. The chaperone
activity catalyzes transient unfolding of the complex secondary structures
in RNA and DNA strand transfer intermediates. We have now asked whether
CCHH or CCCC, which are the zinc binding motifs found in cellular zinc
finger proteins, can be substituted for CCHC and whether the amino acid
context surrounding the CCHC motifs can be changed by exchanging or duplicating
the zinc fingers. Our results demonstrate that, for optimal strand transfer,
the CCHC motifs cannot be replaced by CCHH or CCCC and that the amino
acid context in the loop regions must be preserved. We also find that
the N-terminal zinc finger is a more crucial determinant of NC nucleic
acid chaperone activity than the C-terminal finger. Interestingly, a comparison
of our in vitro results with earlier in vivo replication
data raises the possibility that NC may adopt multiple conformations that
are responsible for different NC functions during virus replication. In
addition to these studies, we are using Fluorescence Resonance Energy
Transfer (FRET) to investigate how NC facilitates nucleic acid rearrangement
during the minus-strand transfer step.
Nucleic Acid and Protein Requirements for Initiation of HIV-1 Reverse
Transcription
Iwatani, Levin in collaboration with Musier-Forsythb
We have recently begun an investigation of the initiation step in HIV-1
reverse transcription. The event is primed by cellular tRNALys3,
which is annealed to the 18-nucleotide priming binding site (PBS) near
the 5' terminus of the viral RNA genome; extension of the primer leads
to synthesis of (-) strong-stop DNA. As a first approach, we have compared
the priming activities of tRNALys3 and
RNA or DNA oligonucleotides with the sequence of the 3' 18 nucleotides
(nt) of the tRNA. Surprisingly, with both the tRNA and 18-nt RNA primers,
at least 24 nt downstream of the PBS must be included in the template
RNA for optimal synthesis of (-) strong-stop DNA, whereas these sequences
are entirely dispensable when a DNA primer is used. The priming activities
of 18-nt chimeric primers, which contain nine RNA bases at the 5' end
followed by nine DNA bases at the 3' end or vice versa, are dictated by
the nature of the 9-nt sequence at the 3' end of the oligonucleotide.
We hypothesize that differences in the helical structures of the RNA and
DNA primers are responsible for the observed differences in activity and
might affect interactions with the template RNA. Experiments to determine
the effect of HIV-1 NC on primer-template requirements are currently in
progress.
Function of HIV-1 Capsid Protein in Virus Assembly and Early Postentry
Events
Tang, Agresta,* Levin in collaboration with Murakami,c
Freed, c Campbelld
Studies on HIV-1 CA have focused on a group of conserved, hydrophobic
residues in the N-terminal portion of the protein. We have now made five
additional alanine substitution mutants. All these mutants have a distinct
phenotype: the resultant virions are noninfectious, exhibit aberrant core
morphology, and are unable to initiate viral DNA synthesis in the infected
cell, although the particles contain a functional reverse transcriptase
enzyme. Taken together, the results reveal the close connection between
proper virion core morphology and the ability to undergo reverse transcription
in vivo. Studies on the protein composition and stability of the
mutant viral cores are now under way.
|
PUBLICATIONS
- Guo
J, Wu T, Anderson J, Kane BF, Johnson DJ, Gorelick RJ, Henderson LE,
Levin JG. The zinc finger structures in the human immunodeficiency
virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand
transfer. J Virol.2000;74:8980-8988.
- Johnson
PE, Turner RB, Wu ZR, Hairston L, Guo J, Levin JG, Summers MF. A
mechanism for plus-strand transfer enhancement by the HIV-1 nucleocapsid
protein during reverse transcription. Biochemistry 2000;39:9084-9091.
- Tang
S, Murakami T, Agresta BE, Campbell S, Rein A, Freed EO, Levin JG.
Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit
aberrant core morphology and are blocked in initiation of reverse transcription
in infected cells. J Virol 2001;75:9357-9366.
*Left NICHD in 1999.
aL.E. Henderson, R.J. Gorelick, AIDS
Vaccine Program, SAIC-Frederick, NCI-FCRDC, Frederick, MD.
bK. Musier-Forsyth, University of Minnesota,
Minneapolis, MN.
cT. Murakami, E.O. Freed, Laboratory
of Molecular Microbiology, NIAID, NIH.
dS. Campbell, HIV Drug Resistance Program,
NCI, NCI-FCRDC, Frederick, MD.
|